DSS Business Summary

DSS, Inc. (NYSE American: DSS) operates as a multinational diversified holding company that generates revenue through a combination of product sales, interest income from commercial lending, and management fees from its investment divisions. The company’s business model is centered on a "venture-builder" strategy, where it acquires undervalued assets, nurtures them to operational maturity, and unlocks shareholder value through strategic spin-offs and IPOs. Its primary business segments include Product Packaging (led by Premier Packaging Corporation), Biotechnology (Impact BioMedical), Commercial Lending (American Pacific Bancorp), and Securities and Investment Management. Within the market, DSS competes with other micro-cap diversified holdings and sector-specific firms such as Xwell, Inc., Greenwave Technology Solutions, and Alset Inc., positioning itself as a high-growth incubator for scalable subsidiaries across fragmented industries. The company is led by Executive Chairman Heng Fai Ambrose Chan, a global restructuring specialist with over 45 years of experience and a track record of transforming more than 35 corporations, including several with multi-billion dollar market capitalizations. Jason T. Grady serves as the Interim CEO and Chief Operating Officer, bringing over 25 years of executive leadership from roles at Berlin Packaging and Parlec Inc., supported by Chief Financial Officer Todd Macko and President Tung Moe Chan. The company’s strategic direction is overseen by a board that includes veteran directors such as Wai Leung William Wu and José Escudero. Notable institutional backing is provided by major shareholders including Alset International Ltd, The Vanguard Group, and Renaissance Technologies, reflecting a stable investor base for its diversified expansion strategy.